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Abstract
The patients’ active participation in their medical care is important for patients with chronic diseases. Measurements of
patient activation are needed for studies and in clinical practice. This study aims to validate the Patient Activation Measure
13 (PAM13-D) in German-speaking primary care patients. This international cross-sectional multicentre study enrolled
consecutively patients from primary care practices in three German-speaking countries: Germany, Austria, and Switzerland.
Patients completed the PAM13-D questionnaire. General Self-Efficacy scale (GSE) was used to assess convergent validity.
Furthermore Cronbach’s alpha was performed to assess internal consistency. Exploratory factor analysis was used to
evaluate the underlying factor structure of the items. We included 508 patients from 16 primary care practices in the final
analysis. Results were internally consistent, with a Cronbach’s alpha of 0.84. Factor analysis revealed one major underlying
factor. The mean values of the PAM13-D correlated significantly (r = 0.43) with those of the GSE. The German PAM13 is a
reliable and valid measure of patient activation. Thus, it may be useful in primary care clinical practice and research.
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Introduction
Chronic illnesses are of growing importance [1] especially in
primary health care [2]. Active participation of patients in their
own medical care is crucial to effective management of chronic
conditions. Being an active and engaged patient in one’s own self-
care is associated with better health outcomes [3,4] and cost
savings [5]. Activated patients also report higher quality of life and
more satisfaction with care [6,7]. Patient activation predicts
health-related behaviours, including self-management, disease
prevention and health-information seeking [8]. Evidence shows
that specific interventions can increase patient activation [9].
Promoting active patient participation in managing their illnesses
is an important task for general practitioners (GPs) [10].
Therefore, the chronic care model seeks to empower patients to
take an active role in their care and supports self-management
[11]. GPs need practical measures to assess patient activity and a
specific measurement is needed for research and clinical practice.
The Patient Activation Measure (PAM) is a reliable and valid
questionnaire that measures patient activation [8]. It is also
available in a 13-item short form (PAM13) [6]. It identifies four
elements of patient activation (knowledge, skills, confidence, and
behaviours critical for coping with a chronic illness) and suggests
four levels of activation that patients reach in becoming fully
engaged in managing their own health [7]. The aim of this study
was to design a culturally-adapted the PAM13-D, and to validate
the questionnaire in a German-speaking primary care population.
Methods
We performed an international multicentre cross-sectional study
in three German speaking countries: Germany, Austria and
Switzerland. The study included adult primary care patients from
general practices. Subjects completed the PAM13-D and General
Self-Efficacy scale (GSE) questionnaires. We obtained ethical
approval for the study from the institutional review boards of
universities in each country.
Recruitment and Data Collection
Data collection was performed by self-rating questionnaires for
approximately 25 patients in each of 19 general practices in
Germany, Austria, and Switzerland. We selected these practices as
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a convenience sample. Each practice team recruited patients for
the trial. For practices to be included, their physicians needed to
be specialists in general medicine or internal medicine in Germany
or have an equivalent qualification in Switzerland and Austria. We
collected data between September 2011 and April 2012, obtaining
written informed consent from all patients prior to inclusion in the
study. Patients were free to discontinue participation in the study
at any time. To be eligible, a subject had to be a registered patient
at the primary care practice study site and be at least 18 years old.
We excluded patients with dementia, blindness, deafness, or
insufficient German language skills to respond to the questions
meaningfully or without informed consent. Emergency patients
were also excluded. Over two practice days, health care assistants
informed all eligible patients about the study and asked them if
they would participate in the study. They then handed out the
questionnaires with opaque envelopes to ensure blinded data
entry. We provided a financial incentive of 50 Euro to each
practice participating in the study.
Translation and Cultural Adaptation
We performed the translation and cultural adaptation of the
PAM13 in accordance with the methodology suggested by the
World Health Organization [12]. The questionnaire was translat-
ed by a health professional, modified by an expert panel consisting
of a psychologist and a physician, then back-translated by an
independent native speaker and cross-checked by the same
psychologist and physician. After performing a pretest on primary
care patients (N= 20), we then adjusted for cultural differences in
the language of the items, creating the final version by consensus.
Measures
PAM13-D. The PAM13-D consists of 13 items on a Likert
scale. Each item has four response categories with scores from 1 to
4: (1) strongly disagree, (2) disagree, (3) agree and (4) agree
strongly. Patient activation is quantified by a sum score ranging
from 13 to 52. Higher scores represent higher levels of patient
activation. We included only questionnaires with answers to seven
or more items in the analyses. In the case of missing data, we
divided the total score by the number of completed items and
multiplied by 13 to get the adjusted sum raw score. We
transformed the adjusted sum raw scores into natural logarithms
to better express relative distances between the scores. Then, we
transformed items from the logit metric to a standardized metric
ranging from 0 to 100 (0 = lowest activation level, 100= highest
activation) to compare the German results to the original data.
From this analysis, it was possible to use the cut-off points
suggested in the test manual to categorize patients into four levels
of activation.
GSE. To assess convergent validity, we used the General Self-
Efficacy questionnaire (GSE) [13]. The GSE is an internationally
standardized one-dimensional questionnaire that measures general
perceptions of self-efficacy. The construct of Perceived Self-
Efficacy reflects an optimistic belief in oneself [14]. This is the
belief that one can perform difficult tasks or cope with adversity in
various domains of human functioning. It can be regarded as a
positive resistance resource factor. The GSE consists of 10 items
on a four-point Likert scale ranging from 1 to 4: (1) not at all true,
(2) hardly true, (3) moderately true, and (4) exactly true. Each item
measures successful coping and implies internally stable attribution
of success. In samples from 23 nations, Cronbach’s alphas for the
GSE ranged from.76 to.90 [13]. Most prominent health behavior
theories include self-efficacy, which is a proximal and direct
predictor of intention and of behavior. According to Bandura’s
social cognitive theory, both an individual’s perception of his or
her ability to perform an action (self-efficacy) and his or her
expectations that the action will have desirable results (outcome
efficacy) are important mediators of performance [15]. Therefore
self-efficacy is clinically relevant as a critical ingredient of
behaviour change.
Construct Validity
Construct validity shows whether an indicator actually measures
the underlying attribute. We examined the construct validity of the
PAM13-D by measuring convergent validity, which assesses if the
postulated dimension of the instrument correlates with other
dimensions that theory suggests should be related to it. In this case,
we checked convergent validity by correlating the PAM and the
GSE. Using Pearson’s product moment correlations, we measured
the correlation of similar dimensions in these instruments that we
expected to be strongly related to each other. We considered
strong correlations to be over 0.60, moderate between 0.30 and
0.60, and low correlations below 0.30 [16].
Data Analysis
To evaluate the PAM13-D questionnaire first means and
standard deviations, and distribution characteristics of the items
were considered. To assess the reliability Cronbach’s alpha as a
characteristic size was calculated. We defined an alpha of 0.80 or
higher as the acceptable value [17–19]. The underlying structure
of the PAM13-D was evaluated by an exploratory factor analysis.
Because we only expected one factor, we used a principle
component analysis for factor extraction with subsequent varimax
rotation [20]. The number of extracting factors was identified by
performing a scree plot. If a factor has a low eigenvalue, it does not
explain much of the variance in the data and may be ignored as
redundant to more important factors. We defined an acceptable
eigenvalue as higher than 1.5. To ensure that the scale items were
relevant for principle component analysis, we performed the
criteria of sampling adequacy (Kaiser-Meyer-Olkin/KMO crite-
rion) before factor extraction, regarding a KMO criterion greater
than 0.5 as a minimum for factor analysis [21] and 0.8 or higher as
optimal [20]. We then calculated item-scale correlation to evaluate
the relevance of single items to the overall measurement. To
determine the convergent validity, we calculated the Pearson
correlation coefficient between the mean sum score of the PAM13-
D and the mean sum score of the GSE. We used multivariate
linear regression analysis to illustrate the influences of health
condition (measured with a 10 point Visual Analogue Scale) and
socio-demographic variables on PAM score. Therefore, variance
of the PAM score as an independent variable was modelled with
the self-reported health status, adjusted for age, gender, centre and
education level. An alpha level of P#0.05 was used for tests of
statistical significance. Statistical analysis was performed using
IBM SPSS 20 for Windows (Chicago, IL, USA).
Results
Study Population
The study included a total of 508 patients (254 female). Patients’
ages ranged from 18 to 89, with a mean age of 54.7 years 616.5
(Table 1). The self-reported health status ranged from 0 to 10, with
a mean of 6.4 (SD=2.1).
Description of the PAM13-D
Table 2 shows the means, standard deviations, and distribution
characteristics (skewness and kurtosis) of the 13 items. The
majority of items show ceiling effects, with a mean of 47.0%.
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The transformed mean of the PAM13-D score, on a scale from 0
to 100, was 68.3 (SD: 14.8).
Internal Reliability
The Cronbach’s alpha coefficient for the full PAM13-D scale of
13 items was 0.84. Using the Pearson’s correlation coefficient, the
item-scale correlation ranged from 0.46 to 0.70 (p,0.01).
Factor Analysis
The measure of sampling adequacy showed an adequate
correlation of items (KMO criterion= 0.87) which met the
requirements for principal component analysis (PCA). The PCA
for factor extraction with subsequent varimax rotation revealed
only one dimension. The eigenvalue of the first PCA factor was
4.5, which explained 34.5% of the variance in the data. All 13
items loaded positively on this single factor (from 0.5 to 0.7).
Figure 1 shows the result of this scree plot.
Convergent Validity
The Pearson correlation coefficient between the mean sum
scores of the PAM13-D and the GSE was 0.43 (p,0.01).
Influence of Health Status
In a multivariate regression model, health status was strongly
associated with PAM13-D mean sum scores (standardized b-value
1.57, P,0.001), explaining 24% of the variance (corrected R2
0.087, P,0.001) if adjusted for age. Education level, gender and
centre showed no significant association with PAM13-D mean
sum scores.
Discussion
We produced a standardised German translation and adapta-
tion of the original PAM13. The forward-backward translation
was successful and small conceptual modifications were made to
adjust for differences in the health care systems. This was similar to
other PAM validations [22]. A sample of at least 400 patients is
necessary to appropriately evaluate a questionnaire [23]. Our
study included 508 patients. The results of our psychometric
assessment of the German version of the PAM13 replicated the
findings from other translated versions [22], showing similar data
quality and internal consistency.
Unlike the original PAM, the German Version showed lower
internal reliability and higher patient activation scores. We suggest
three factors that may account for these differences. 1) Hetero-
geneity of samples: Primary care samples recruited in general
practice contain a wide range of patients, including both patients
undergoing routine examinations and patients with multimorbid-
ity. 2) Recruitment: Our recruitment strategy was a low-limited.
Most of the patients were eligible and could be included, but
patients received no financial compensation. And 3) Statistical
methodology: While the authors of the original PAM suggest
removing patients with extreme levels of activation from the data
in order to control for responses biased by social desirability, we
analyzed the complete data. Exclusion would have removed 20
patients and reduced the mean value of activation from 68.3 to
67.2 [24]. However, it is difficult to differentiate between patients
reporting high levels of activation for social desirability and those
who have actually achieved high levels of activation. Using a
trimmed mean can lead to biased inferences [25]. Thus, we chose
to analyze the data completely, following the methodological
guidelines for the validation of an instrument. Our inclusion of
patients with the highest possible levels of activation may explain
our findings of increased activation levels, indicating ceiling effects
in the German PAM13-D.
Our exploratory factor analysis of the PAM13-D indicated a
homogenous factor structure with all items loading on one factor.
We labeled this factor ‘‘patient activation’’. The measure of
sampling adequacy showed a good correlation of items, but the
explained variance is not very high because there are other factors
with an eigenvalue near 1. This suggests that other factors could be
included, but that these are not statistically significant. The
correlation between the means of the PAM13-D and the GSE was
significant, providing evidence for the construct validity of the
instrument. According to both our expectations and previous study
results, we observed a positive association between self-reported
health status and patient activation [26–28].
The strengths of the study include its international multicentre
design in primary care settings and its systematic process of
translation and cultural adaptation, as recommended by the
World Health Organization [12]. Limitations of this study include
cultural differences between the health systems of each study
country and a possible selection bias of patients due to self-
selection (resulting in ceiling effects). In addition, we had no
information about the diagnoses of the patients or the presence of
multimorbidity. This should be considered in future studies.
Furthermore, the cross-sectional design of this study does not allow
for calculation of the retest reliability because we only have one
measurement point. Longitudinal validation studies should be
performed before conclusions can be drawn about reproducibility
of a patient’s score, test-retest reliability and measurement of
intervention effects. The discriminant validity can also be
determined by other instruments which could also be included
in future studies. Successful evaluation of discriminant validity
shows that a test of a concept is not highly correlated with other
tests designed to measure theoretically different concepts [29].
Additional qualitative interviews with experts (GPs) might improve
the quality of the items. Our results cannot be generalized beyond
a primary care population because our sample was drawn from
that specific patient population. Additional studies still need to
validate the PAM13-D in other settings, in special chronic patient
Table 1. Description of the study population (N = 508).
Characteristics Subcharacteristics n %
Sex Male 249 49.0
Female 259 51.0
Age Under 29 42 8.3
30–39 y 49 9.6
40–49 y 103 20.3
50–59 y 100 19.7
60–69 y 100 19.7
70 and older 114 22.4
Education Middle school 136 26.8
Secondary modern school 192 37.8
High school 167 32.9
Missing 13 2.5
Study Centre Jena (Germany) 135 26.6
Heidelberg (Germany) 114 22.4
Salzburg (Austria) 132 26.0
Zu¨rich (Switzerland) 127 25.0
doi:10.1371/journal.pone.0074786.t001
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populations for example, in order to compare the level of
activation for those groups of patients with different chronic
conditions as well. Further research might analyze effects of
patient activation on co-existing chronic diseases.
Conclusions
The German Patient Activation Measure 13, the PAM13-D,
appears to be a valid and reliable questionnaire to assess patient
activation in primary care patients. The measure has good
psychometric properties and appears to tap into the developmental
character of activation. Its strong reliability supports its use as a
tool for measurement in individual patients and may provide
beneficial information to GPs individualizing patient care plans.
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